Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

pCMVTNT™ Vector

Instructions for Use of Product(s)
L5620

Literature # TB305

The pCMVTNT™ Vector is designed for convenient expression of cloned genes using in vivo or in vitro expression systems. Both the SP6 and T7 polymerase promoters lie in tandem adjacent to the multiple cloning site, allowing highly efficient synthesis of RNA in vitro from either promoter. Protein can be expressed in vitro from a gene cloned into the pCMVTNT™ Vector using an SP6- or T7-based in vitro transcription/translation system. The pCMVTNT™ Vector contains a 5´ ß-globin leader sequence reported to enhance expression of certain genes in vitro. For in vivo expression, the vector contains a cytomegalovirus (CMV) enhancer/promoter region that allows strong constitutive expression in many cell types. A ß-globin/IgG chimeric intron and a late SV40 polyadenylation site are located downstream from the enhancer/promoter region.

Summary of Changes: 9/14 Revision
The following change was made in the 9/14 revision of this document:
Patent and licensing information was updated.

Printed in USA. Revised 9/14.